BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12766571)

  • 1. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
    Droste JA; Verweij-Van Wissen CP; Burger DM
    Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
    Dailly E; Thomas L; Kergueris MF; Jolliet P; Bourin M
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):129-35. PubMed ID: 11486821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
    Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
    Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
    Keil K; Frerichs VA; DiFrancesco R; Morse G
    Ther Drug Monit; 2003 Jun; 25(3):340-6. PubMed ID: 12766563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
    Verbesselt R; Van Wijngaerden E; de Hoon J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
    Weller DR; Brundage RC; Balfour HH; Vezina HE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
    Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
    Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of the five HIV-protease inhibitors: amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Radembino N; Robidou P; Jaillon P
    Ther Drug Monit; 2000 Aug; 22(4):465-73. PubMed ID: 10942189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.
    van Heeswijk RP; Hoetelmans RM; Harms R; Meenhorst PL; Mulder JW; Lange JM; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):159-68. PubMed ID: 9869376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Choi SO; Rezk NL; Kashuba AD
    J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
    Yamada H; Kotaki H; Nakamura T; Iwamoto A
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):85-9. PubMed ID: 11393736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
    Hirabayashi Y; Tsuchiya K; Kimura S; Oka S
    Biomed Chromatogr; 2006 Jan; 20(1):28-36. PubMed ID: 15971289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
    Villani P; Feroggio M; Gianelli L; Bartoli A; Montagna M; Maserati R; Regazzi MB
    Ther Drug Monit; 2001 Aug; 23(4):380-8. PubMed ID: 11477320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
    Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
    Dailly E; Raffi F; Jolliet P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):353-8. PubMed ID: 15556553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
    Bouley M; Briere C; Padoin C; Petitjean O; Tod M
    Ther Drug Monit; 2001 Feb; 23(1):56-60. PubMed ID: 11206045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.